Page 5 - Davidr Martinez News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Davidr martinez. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Davidr Martinez Today - Breaking & Trending Today

New universal coronavirus vaccine could prevent future pandemics - UNC News


New universal coronavirus vaccine could prevent future pandemics
Study from University of North Carolina at Chapel Hill shows a vaccine could be effective against COVID-19, its variants and future coronavirus pandemics
Shantell M. Kirkendoll ,
Tuesday, June 22nd, 2021
David R. Martinez in the lab on the University of North Carolina at Chapel Hill campus. Photo by Jon Gardiner at UNC-Chapel Hill.
CHAPEL HILL, N.C. – Scientists at the University of North Carolina Gillings School of Global Public Health have developed a vaccine that could be effective against COVID-19, its variants and a future coronavirus pandemic.
While no one knows which virus may cause the next outbreak, coronaviruses remain a threat after causing the SARS outbreak in 2003 and the global COVID-19 pandemic. ....

South Africa , North Carolina , United States , University Of North Carolina , Duke University , Chapel Hill , Hannah Gray , Jon Gardiner , Davidr Martinez , Gillings School Of Global Public Health , Duke University School Of Medicine , School Of Medicine , University Of Pennsylvania Perelman School Medicine , Gilings School Of Global Public Health , National Institutes Of Health , National Institutes Of Allergy , University Of North Carolina At Chapel Hill , Howard Hughes Medical Institute , North Carolina Gillings School , Global Public Health , Chapel Hill , Ralph Baric , Epidemiologist Ralph Baric , Global Public , Duke University School , Pennsylvania Perelman School ,

Single-dose COVID-19 vaccine effective against variants, study says


In the three months since Johnson & Johnson’s COVID-19 vaccine received emergency use authorization from the U.S. Food and Drug Administration, more than 10 million Americans have received the vaccine, according to the Centers for Disease Control and Prevention. The single-shot viral vector vaccine developed in collaboration with Beth Israel Deaconess Medical Center (BIDMC) immunologist Dan Barouch was authorized for use based on clinical trial data showing strong clinical efficacy against symptomatic COVID-19 in the United States, Latin America and South Africa.
In a new study published in Nature, Barouch, director of BIDMC’s Center for Virology and Vaccine Research, and colleagues report on the antibody and cellular immune responses generated by the Ad26.COV2.S vaccine against the original viral strain and against SARS-CoV-2 variants of concern. The team found that this vaccine induced immune responses against all the viral variants.   ....

United States , South Africa , United Kingdom , Jinyan Liu , Erican Borducchi , Sally Shin , Lisah Tostanoski , Frank Struyf , Caroline Atyeo , Macaya Douoguih , Kathryne Stephenson , Dirk Heerwegh , Katherine Mcmahan , Hanneke Schuitemaker , Dan Barouch , Hannahh Gray , Michelle Lifton , Aiquan Chang , Davidr Martinez , Abishek Chandrashekar , Harlan Robins , Jingyou Yu , Jerald Sadoff , Joseph Nkolola , Brian Kaplan , Catherine Jacob Dolan ,